Posture Pandemic Declared as 1 in 3 Australians Now Suffer Chronic Neck Pain, Reports North Shore Family Chiropractors
SYDNEY, NEW SOUTH WALES, AUSTRALIA, July 20, 2025 / EINPresswire.com / -- North Shore Family Chiropractors has released a new analysis revealing a marked rise in chronic neck pain across the Australian population. One in three adults now experience ongoing symptoms linked to cervical spine dysfunction. The trend is being described by health experts as a 'posture pandemic,' reflecting the widespread nature of this emerging issue and its growing impact on daily life, productivity, and national healthcare costs.
The condition affects a broad demographic, spanning students, office workers, manual laborers, and adolescents. Lifestyle factors such as prolonged digital device use, sedentary routines, and elevated stress levels are cited as key contributors. The average working adult in Australia spends approximately 6.8 hours per day looking at screens, contributing to forward head posture and tension known as 'tech neck.' Extended time in fixed positions, especially with poor ergonomic setups, places sustained strain on the neck, upper back, and shoulders, leading to muscular imbalances, joint misalignment, and chronic pain patterns.
The report outlines several underlying causes of the condition. Poor workstation design, unsupported furniture, and lack of regular movement contribute to mechanical stress in the cervical spine. Mental stress and elevated workloads increase muscle tension, particularly in the neck and shoulders, compounding physical strain. Decreased physical activity reduces muscular support in postural stabilisers, weakening the spine's ability to absorb mechanical load. These factors together form a cycle that can evolve from temporary discomfort into long-term musculoskeletal disorders.
Dr Darren Leukefeld, principal chiropractor at North Shore Family Chiropractors, reports a significant rise in patients presenting with related symptoms, some as young as 14 years old. Persistent neck pain is no longer confined to older adults or those with previous injury. The shift in population-level habits and physical patterns has created new risks across age groups, occupations, and lifestyles. Without intervention, individuals may face long-term effects including recurring migraines, nerve compression, restricted mobility, and related mental health challenges.
In addition to the human toll, chronic musculoskeletal issues present a financial challenge. Current estimates place the cost of these conditions at over $55 billion annually in Australia, with neck pain contributing to lost productivity, increased absenteeism, and long-term disability claims. The cumulative effect on both the healthcare system and the workforce underscores the urgency for early recognition and targeted intervention.
North Shore Family Chiropractors emphasises the importance of postural awareness and preventative care. Early identification of symptoms and professional assessment are critical in reducing long-term complications. Simple changes such as improved ergonomics, regular stretching, movement breaks, and spinal health assessments may reduce the risk of progression. The clinic encourages individuals, employers, and educators to consider the long-term implications of sedentary routines and take proactive steps to address them.
To learn more about contributing factors and available management options, visit North Shore Family Chiropractors' educational guide Neck Pain: Causes, Symptoms, and Chiropractic Care for Relief.
Website: https://northshorechiro.com.au/
Helen
North Shore Family Chiropractors
[email protected]
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a minute ago
- Yahoo
UnitedHealth Stock Is Having Its Worst Year Since 2008. Can It Recover?
Key Points It isn't typical for UnitedHealth stock to finish a year lower than it started, let alone be down more than 40% as it is right now. Rising costs and uncertainty around healthcare reform are just a couple of the issues plaguing the stock. It's trading around multiyear lows, however, and is arguably a cheap buy. 10 stocks we like better than UnitedHealth Group › For years UnitedHealth Group (NYSE: UNH) has normally been a reliable dividend stock. But an abysmal start to 2025 has wiped out many of the gains that investors have achieved in recent years, with its five-year return now in negative territory. Year to date, the stock has fallen by nearly 45%, which is by no means normal for the healthcare stock. In fact, this is the worst it has performed since the Great Recession, when it tumbled by more than 54% in 2008. The big questions many investors are likely asking today are: Can it recover? Or is there more of a downfall to come for this once seemingly unstoppable stock? Big declines aren't the norm for UnitedHealth The past few years haven't been all that great for UnitedHealth, but by and large, this has been a fairly strong stock to own. It has typically outperformed the market. And outside of 2024 -- when it was down 4% -- the last time it finished a year in the red was (as noted) back in 2008, when the U.S. economy was in the midst of the Great Recession and the stock lost more than half of its value. Not only has UnitedHealth normally been a safe stock, it's also been a tremendous growth stock. Consider that if you invested $10,000 into its shares at the end of 2003, then 20 years later your investment would have been worth $181,000. But if you hung on until now, that investment would have fallen to a value of $101,000. While that's still a good return, it spotlights just how significant the decline has been this year, for a stock that's typically known for being a solid long-term investment. Still, the past doesn't predict the future. Why the company might face a tough road ahead The problem with UnitedHealth right now is that it's facing many challenges. Medical costs are up, and there's a lot of uncertainty in healthcare as the federal government looks to cut costs. Meanwhile, the Department of Justice is reportedly looking into UnitedHealth's billing practices. The danger is that the company may face financial repercussions and other headwinds, such as having to change its practices -- or at the very least, incurring higher-than-typical costs due to greater utilization rates. The latter, however, may be a shorter-term trend. Either way, this is a business known for consistently growing its operations, and that may not be a sure thing anymore. While UnitedHealth generated a healthy profit of more than $14.4 billion on revenue of $400.3 billion in 2024, investor concerns about long-term growth appear to be weighing on the stock. In May, the company suspended its outlook for the year; it also announced a change in CEO, with Andrew Witty stepping down for personal reasons and former CEO Stephen Hemsley taking over. Should you buy UnitedHealth stock today? While UnitedHealth stock has done well in previous years, that doesn't mean that it's a surefire bet to rebound soon. The good news is that it still has solid fundamentals. Since it's a key health insurer in the U.S., I'd be hesitant to count it out in the long run. There's some near-term risk and even some long-term uncertainty about how all the changes in the healthcare industry might pan out. But the stock is trading at levels it hasn't been at since 2020, and its valuation is just 12 times its trailing earnings. I think that gives it a good enough margin of safety at its current price, and that buying it today might prove to be a solid move. As long as you're willing to be patient, this can be a good stock to buy and hold. Should you buy stock in UnitedHealth Group right now? Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,628!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,063,471!* Now, it's worth noting Stock Advisor's total average return is 1,041% — a market-crushing outperformance compared to 183% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 28, 2025 David Jagielski has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy. UnitedHealth Stock Is Having Its Worst Year Since 2008. Can It Recover? was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Obesity to fuel rise in liver cancer cases
The number of cases of liver cancer are set to double by 2050, with rising cases of obesity partly to blame, academics have said. The proportion of cases of liver cancer linked to obesity are set to increase from 5% to 11%, a group of experts has said as they called for more to be done to tackle preventable cases from occurring in the first place. The number of new liver cancers around the world will rise from 0.87 million in 2022 to 1.52 million in 2050, according to projections published as part of a new Lancet Commission on Liver Cancer paper. Researchers said that the proportion of liver cancers caused by the most common cause of liver cancer – the hepatitis B virus – are set to reduce over the coming years. Cases caused by the hepatitis C virus are also expected to decline proportionately. But in contrast, liver cancer cases caused by alcohol and obesity are set to increase. Experts predicted that by 2050 some 21% of liver cancers will be caused by alcohol. And 11% will be caused by a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) – formerly known as fatty liver disease, where fat builds up in a person's liver. The severe form of this condition is called metabolic dysfunction-associated steatohepatitis. The research team point out that 60% of liver cancers are preventable. They said that global deaths from liver cancer are expected to rise from 760,000 in 2022 to 1.37 million in 2050. 'These data suggest that preventive measures targeting a comprehensive number of risk factors for hepatocellular carcinoma are sorely needed,' the team of experts led by academics in Hong Kong wrote. The main treatment for MASLD is eating a balanced diet, being physically active and potentially losing weight. 'Liver cancer is a growing health issue around the world,' said Professor Jian Zhou, chairman of the Commission from Fudan University in China. 'It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5% to 30%. 'We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend.' First author, Professor Stephen Chan, from the Chinese University of Hong Kong, added: 'As three in five cases of liver cancer are linked to preventable risk factors, mostly viral hepatitis, alcohol and obesity, there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer and save lives.' Commenting on the study, Pamela Healy, chief executive of the British Liver Trust, said: 'Liver cancer is the fastest rising cause of cancer death in the UK, and just 13% of people diagnosed will survive for five years or more. 'We know that the biggest risk factors are having pre-existing liver cirrhosis or viral hepatitis, and this new analysis highlights that MASLD, also known as fatty liver disease, is expected to be linked to an increasing number of cases. 'As well as improving early detection through surveillance of people with cirrhosis, it is essential that we tackle these underlying causes and prioritise public health. 'By supporting people to maintain a healthy weight, cut down on alcohol and get tested and treated for hepatitis, we can prevent many cases of liver cancer and save lives.' In 2022, some 64% of adults in England were estimated to be overweight or living with obesity.
Yahoo
2 hours ago
- Yahoo
Rising obesity rates will see cases of liver cancer double by 2050, study warns
The number of cases of liver cancer are set to double by 2050, academics have said. The rising cases of obesity are partly to blame. The proportion of cases of liver cancer linked to obesity are set to increase from 5 per cent to 11 per cent, a group of experts has said. They also called for more to be done to tackle preventable cases from occurring in the first place. The number of new liver cancers around the world will rise from 0.87 million in 2022 to 1.52 million in 2050, according to projections published as part of a new Lancet Commission on Liver Cancer paper. Researchers said that the proportion of liver cancers caused by the most common cause of liver cancer – the hepatitis B virus – are set to reduce over the coming years. Cases caused by the hepatitis C virus are also expected to decline proportionately. But in contrast, liver cancer cases caused by alcohol and obesity are set to increase. Experts predicted that by 2050 some 21 per cent of liver cancers will be caused by alcohol. And 11 per cent will be caused by a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) – formerly known as fatty liver disease, where fat builds up in a person's liver. The severe form of this condition is called metabolic dysfunction-associated steatohepatitis. The research team point out that 60 per cent of liver cancers are preventable. They said that global deaths from liver cancer are expected to rise from 760,000 in 2022 to 1.37 million in 2050. 'These data suggest that preventive measures targeting a comprehensive number of risk factors for hepatocellular carcinoma are sorely needed,' the team of experts led by academics in Hong Kong wrote. The main treatment for MASLD is eating a balanced diet, being physically active and potentially losing weight. 'Liver cancer is a growing health issue around the world,' said Professor Jian Zhou, chairman of the Commission from Fudan University in China. 'It is one of the most challenging cancers to treat, with five-year survival rates ranging from approximately 5 per cent to 30 per cent. 'We risk seeing close to a doubling of cases and deaths from liver cancer over the next quarter of a century without urgent action to reverse this trend.' First author, Professor Stephen Chan, from the Chinese University of Hong Kong, added: 'As three in five cases of liver cancer are linked to preventable risk factors, mostly viral hepatitis, alcohol and obesity, there is a huge opportunity for countries to target these risk factors, prevent cases of liver cancer and save lives.' Commenting on the study, Pamela Healy, chief executive of the British Liver Trust, said: 'Liver cancer is the fastest rising cause of cancer death in the UK, and just 13 per cent of people diagnosed will survive for five years or more. 'We know that the biggest risk factors are having pre-existing liver cirrhosis or viral hepatitis, and this new analysis highlights that MASLD, also known as fatty liver disease, is expected to be linked to an increasing number of cases. 'As well as improving early detection through surveillance of people with cirrhosis, it is essential that we tackle these underlying causes and prioritise public health. 'By supporting people to maintain a healthy weight, cut down on alcohol and get tested and treated for hepatitis, we can prevent many cases of liver cancer and save lives.' In 2022, some 64 per cent of adults in England were estimated to be overweight or living with obesity.
